Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Kennard

Showing results (41-50 of 63) with videos related to

Pageof 7
Sort By:
Fertility and Sterility|November 7, 1998
Elevated level of follicular fluid vascular endothelial growth factor is a marker of diminished pregnancy potentialC I Friedman, D B Seifer, E A Kennard, et al.
Behavioural Brain Research|August 11, 2011
The context preexposure facilitation effect in mice: a dose-response analysis of pretraining scopolamine administrationKevin L Brown, John A Kennard, Daniel J Sherer, et al.
Obstetrics and Gynecology|May 1, 1993
Cigarette smoking and levels of maternal serum alpha-fetoprotein, unconjugated estriol, and hCG: impact on Down syndrome screeningG E Palomaki, G J Knight, J E Haddow, et al.
Fertility and Sterility|December 16, 1998
Activin A stimulates meiotic maturation of human oocytes and modulates granulosa cell steroidogenesis in vitroB M Alak, S Coskun, C I Friedman, et al.
Gynecologic Oncology|October 23, 2021
A phase 1b study of intraperitoneal oncolytic viral immunotherapy in platinum-resistant or refractory ovarian cancerMadhavi Manyam, Amanda J Stephens, Jessica A Kennard, et al.
BMJ (Clinical Research Ed.)|November 18, 1995
Decision analysis and screening for Down's syndrome. Testing should be in all womenN J Wald, A Kennard, H Watt, et al.
Fertility and Sterility|April 1, 1989
A program for matched, anonymous oocyte donationE A Kennard, R L Collins, J Blankstein, et al.
Gynecologic Oncology|February 27, 2022
Corrigendum to "A phase 1b study of intraperitoneal oncolytic viral immunotherapy in platinum-resistant or refractory ovarian cancer" [Gynecologic Oncology 163 (2021) 481-489]Madhavi Manyam, Amanda J Stephens, Jessica A Kennard, et al.
Fertility and Sterility|December 16, 1998
Effects of ovarian source, patient age, and menstrual cycle phase on in vitro maturation of immature human oocytesK S Whitacre, D B Seifer, C I Friedman, et al.
Fertility and Sterility|July 11, 1998
Dimeric inhibin: a direct marker of ovarian agingD R Danforth, L K Arbogast, J Mroueh, et al.
Pageof 7

Showing results (41-50 of 63) with videos related to

Sort By:
Pageof 7
Fertility and Sterility|November 7, 1998
Elevated level of follicular fluid vascular endothelial growth factor is a marker of diminished pregnancy potentialC I Friedman, D B Seifer, E A Kennard, et al.
Behavioural Brain Research|August 11, 2011
The context preexposure facilitation effect in mice: a dose-response analysis of pretraining scopolamine administrationKevin L Brown, John A Kennard, Daniel J Sherer, et al.
Obstetrics and Gynecology|May 1, 1993
Cigarette smoking and levels of maternal serum alpha-fetoprotein, unconjugated estriol, and hCG: impact on Down syndrome screeningG E Palomaki, G J Knight, J E Haddow, et al.
Fertility and Sterility|December 16, 1998
Activin A stimulates meiotic maturation of human oocytes and modulates granulosa cell steroidogenesis in vitroB M Alak, S Coskun, C I Friedman, et al.
Gynecologic Oncology|October 23, 2021
A phase 1b study of intraperitoneal oncolytic viral immunotherapy in platinum-resistant or refractory ovarian cancerMadhavi Manyam, Amanda J Stephens, Jessica A Kennard, et al.
BMJ (Clinical Research Ed.)|November 18, 1995
Decision analysis and screening for Down's syndrome. Testing should be in all womenN J Wald, A Kennard, H Watt, et al.
Fertility and Sterility|April 1, 1989
A program for matched, anonymous oocyte donationE A Kennard, R L Collins, J Blankstein, et al.
Gynecologic Oncology|February 27, 2022
Corrigendum to "A phase 1b study of intraperitoneal oncolytic viral immunotherapy in platinum-resistant or refractory ovarian cancer" [Gynecologic Oncology 163 (2021) 481-489]Madhavi Manyam, Amanda J Stephens, Jessica A Kennard, et al.
Fertility and Sterility|December 16, 1998
Effects of ovarian source, patient age, and menstrual cycle phase on in vitro maturation of immature human oocytesK S Whitacre, D B Seifer, C I Friedman, et al.
Fertility and Sterility|July 11, 1998
Dimeric inhibin: a direct marker of ovarian agingD R Danforth, L K Arbogast, J Mroueh, et al.
Pageof 7